Preparation method of pumpkin pedicel dropping pills

Through the microencapsulation technology of polylactic acid-glycolic acid copolymerized PLGA and chitosan composite matrix, the stability and portability of pumpkin tetsu preparations are solved, and the effective ingredients of pumpkin tetsu drop pills are gradually released and stored in the body. Suitable for young people's usage habits.

CN118948785AInactive Publication Date: 2024-11-15廖园红
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411309675.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-19
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing pumpkin stem preparation method is not suitable for young people's use habits, and the active ingredients are easily lost during storage and transportation, and have poor stability.

Method used

Plumbing leech extract concentrate is encapsulated by microencapsulation technology, and pumpkin leech drop pills are prepared by liquid nitrogen condensation method to ensure the gradual release of the drug in the body and improve the stability of the active ingredients. and portability ease.

Benefits of technology

Through microencapsulation technology to encapsulate the active ingredients, the pumpkin pilogue pills are gradually released in the body, exerting continuous biological activity, improving the stability and storage of the drug, and suitable for long-distance transportation and storage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948785A_ABST
    Figure CN118948785A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of a pumpkin pedicel dropping pill, and belongs to the technical field of traditional Chinese medicine preparations, and the preparation method comprises the following steps: S1, preparing a compound matrix: mixing polylactic acid-glycolic acid copolymer PLGA and chitosan according to a certain proportion, and compounding by a chemical method to prepare the matrix of the dropping pill; s2, microencapsulation: encapsulating the extracted concentrated solution into a compound matrix through emulsification to form microcapsules, and ensuring that the microcapsules have good sphericity and uniform particle size. According to the pumpkin pedicel dropping pill and the preparation method thereof, the active ingredients can be encapsulated in the dropping pill through a microencapsulation technology, so that the active ingredients are gradually released in vivo, the continuous biological activity is exerted, the stability of the active ingredients can be improved through the compound matrix and the microencapsulation technology, and the degradation and loss of the active ingredients in the preparation and storage processes can be prevented. And the pumpkin pedicel dropping pill is a solid preparation, is convenient to carry and take, and can keep good stability and effectiveness especially in the long-distance transportation and storage process.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of traditional Chinese medicine preparations, in particular to a method for preparing pumpkin stalk dropping pills. Background Art

[0002] The dripping pill dosage form is a solid dispersion dosage form, which is formed by heating the drug and the matrix to a molten state to form a solution, emulsion or suspension, and then dripping it into an immiscible condensate through a dripping technique. Due to the effect of surface tension, the droplets will shrink rapidly and solidify in the condensate, eventually forming a small pill-shaped preparation, namely the dripping pill.

[0003] The existing pumpkin stalks are mostly prepared by cutting the stalks of mature pumpkins in autumn, drying them, and taking them in the form of decoction or powder or applying the powder externally to treat various diseases, such as carbuncle, furuncle, burn, ulcer that does not heal, edema ascites and fetal movement disorder, etc. However, young people are not satisfied with the way of boiling Chinese medicine, so a preparation method of pumpkin stalk pills is proposed.

[0004] The above information disclosed in this background technology is only used to increase the understanding of the background technology of the present invention and therefore, it may include information that does not constitute the prior art known to ordinary technicians in this field. Summary of the invention

[0005] The present invention aims to solve at least one of the technical problems existing in the prior art. To this end, one object of the present invention is to provide a method for preparing pumpkin pedicle dripping pills.

[0006] To achieve the above object, the present invention provides the following technical solutions:

[0007] A method for preparing pumpkin pedicle dripping pills comprises the following steps:

[0008] S1. Preparation of composite matrix: polylactic acid-co-glycolic acid PLGA and chitosan are mixed in a certain proportion, and compounded by chemical method to prepare a matrix of drop pills;

[0009] S2. Microencapsulation: The extract concentrate is encapsulated into a composite matrix by emulsification to form microcapsules, and the microcapsules are ensured to have good sphericity and uniform particle size;

[0010] S3. Condensation granulation: put the prepared microcapsules into a pill machine, use liquid nitrogen as a cooling medium to drop the microcapsules into the cooling medium, and quickly condense to form solid pills. Collect the condensed pills, dry them, remove the residual cooling medium, and obtain the final pumpkin pedicle pills.

[0011] As a further optimization scheme of the present invention, in step S1, the specific steps are:

[0012] Weigh PLGA and chitosan in a ratio of 90:10-70:30, pre-dry the PLGA particles at room temperature to remove moisture to ensure that it dissolves with the chitosan during the mixing process, add the chitosan to a 1-2% acetic acid solution, heat and stir until the chitosan is completely dissolved;

[0013] Carboxyl groups with reactive groups were introduced into chitosan molecules, and PLGA introduced amine groups through chemical reactions to promote the binding with chitosan;

[0014] The pre-dried PLGA particles were added to the dissolved chitosan solution and the mixture was stirred at room temperature using a magnetic stirrer to ensure that the PLGA and chitosan were evenly distributed for 1-2 h;

[0015] After compounding by chemical methods, the prepared composite matrix is ​​characterized to confirm the structure and properties of the composite matrix.

[0016] As a further optimization scheme of the present invention, the specific steps of compounding PLGA and chitosan by chemical method are as follows:

[0017] The functionalized PLGA and chitosan are mixed together, and in the presence of carbodiimide, the carboxyl groups on the PLGA react with the amine groups on the chitosan to form amide bonds, the pH value is maintained at 4.5-6.5, the reaction temperature is 30°C-60°C, the reaction time is 40-90 minutes, and dimethylformamide is used to dissolve the PLGA and chitosan without interfering with the amidation reaction. After the reaction is completed, unreacted raw materials and by-products are removed by dialysis and centrifugation, and the composite matrix is ​​washed and dried to obtain a pure composite.

[0018] As a further optimization scheme of the present invention, in step S2, the specific steps of preparing microcapsules using emulsification technology are:

[0019] Phospholipids are selected as emulsifiers, and the oil phase and the water phase are mixed in a ratio of 6:1. A homogenizer is used for preliminary emulsification to form colostrum; the colostrum is processed by a high-pressure homogenizer to reduce the size of the droplets to form a more uniform emulsion, and glutaraldehyde is added to initiate cross-linking of the polymer in the composite matrix, thereby solidifying the droplets in the emulsion to form microcapsules; the microcapsules are separated by centrifugation and filtration, and the microcapsules are washed with ethanol to remove residual emulsifiers, unreacted polymers and impurities. The washed microcapsules are vacuum dried to remove moisture to obtain dry microcapsules, and finally the prepared microcapsules are subjected to particle size analysis, morphological observation, drug loading and encapsulation efficiency determination to confirm the quality of the microcapsules.

[0020] As a further optimization scheme of the present invention, in S3, the specific steps of condensation granulation are:

[0021] Preheat the dripping head of the pill machine to reduce the adhesion of microcapsules during the dripping process, and transport the prepared microcapsules to the hopper of the pill machine through the conveying device to ensure that the microcapsules are evenly distributed in the hopper to avoid clogging the dripping head; pour liquid nitrogen into a low-temperature resistant container as a cooling medium, prepare liquid nitrogen, start the pill machine, and drip the microcapsules into the liquid nitrogen through the dripping head. Control the distance between the dripping head and the surface of the liquid nitrogen, and keep the distance at 3 cm to ensure that the microcapsules can be quickly condensed when dripped into the liquid nitrogen; after the microcapsules come into contact with the liquid nitrogen, they quickly lose heat, causing the internal matrix and shell materials to solidify quickly, and the microcapsules form a solid state in the liquid nitrogen while maintaining a spherical shape. After condensation Solid pellets float on the surface of liquid nitrogen. Use a funnel to collect the pellets from the liquid nitrogen and transfer the collected pellets to a dryer for vacuum drying to remove residual liquid nitrogen and moisture. Start drying at below 0°C and then gradually increase the temperature to no more than 40°C to avoid destroying the active ingredients of the drug. The drying time is 8-24 hours. During the drying process, the residual liquid nitrogen sublimates along with the moisture and is removed. Turn off the vacuum dryer and let the pellets cool naturally to room temperature in the dryer. Screen the dried pellets to remove unqualified particles and perform quality inspections on the particle size, weight, drug content and drug release characteristics of the pellets.

[0022] As a further optimization scheme of the present invention, in step S2, the specific steps for extracting the concentrated solution are:

[0023] S201. Select fresh, pest-free pumpkin pedicles as raw materials, wash the pumpkin pedicles, remove the dirt and impurities on the surface, and chop the pumpkin pedicles;

[0024] S202. The pretreated pumpkin pedicles were mixed with an extraction solvent in a ratio of 1:10 by an ultrasonic extraction method, and extracted using an ultrasonic extractor. The temperature during the extraction process was set to 25-50 ° C, the time was 15-60min, and the power was 200-800W;

[0025] S203. The extract is concentrated under reduced pressure to remove the solvent to obtain a concentrate, and the temperature and pressure are controlled during the concentration process to avoid decomposition and loss of the active ingredient;

[0026] S204. The concentrated solution is purified to remove impurities, and finally the drug content and active ingredients of the extract are identified.

[0027] Compared with the prior art, the present invention has the following beneficial effects:

[0028] The present invention can encapsulate the active ingredients in the pills through microencapsulation technology, so that they are gradually released in the body and exert sustained biological activity. The pumpkin pedicle pills can improve the stability of the active ingredients through the composite matrix and microencapsulation technology, and prevent the degradation and loss of the active ingredients during the preparation and storage process. The pumpkin pedicle pills are solid preparations, which are easy to carry and take, and can maintain good stability and effectiveness, especially during long-distance transportation and storage.

[0029] The above summary is for illustrative purposes only and is not intended to be limiting in any way. In addition to the illustrative aspects, embodiments and features described above, further aspects, embodiments and features of the present invention will be readily apparent by reference to the accompanying drawings and the following detailed description. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 The present invention is a flow chart of the preparation method of pumpkin stalk dropping pills. DETAILED DESCRIPTION

[0031] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0032] See also Figure 1 , the present invention provides a technical solution:

[0033] A method for preparing pumpkin pedicle dripping pills comprises the following steps:

[0034] S1. Preparation of composite matrix: polylactic acid-co-glycolic acid PLGA and chitosan are mixed in a certain proportion, and compounded by chemical method to prepare a matrix of drop pills;

[0035] The specific steps are as follows: weigh PLGA and chitosan in a ratio of 90:10-70:30, pre-dry the PLGA particles at room temperature to remove moisture to ensure that it dissolves with the chitosan during the mixing process, add the chitosan to an acetic acid solution with a concentration of 1-2%, heat and stir until the chitosan is completely dissolved;

[0036] Carboxyl groups with reactive groups were introduced into chitosan molecules, and PLGA introduced amine groups through chemical reactions to promote the binding with chitosan;

[0037] The pre-dried PLGA particles were added to the dissolved chitosan solution and the mixture was stirred at room temperature using a magnetic stirrer to ensure that the PLGA and chitosan were evenly distributed for 1-2 h;

[0038] The functionalized PLGA and chitosan are mixed together, and in the presence of carbodiimide, the carboxyl groups on the PLGA react with the amine groups on the chitosan to form amide bonds, the pH value is maintained at 4.5-6.5, the reaction temperature is 30°C-60°C, the reaction time is 40-90min, and dimethylformamide is used to dissolve the PLGA and chitosan without interfering with the amidation reaction. After the reaction is completed, unreacted raw materials and by-products are removed by dialysis and centrifugation, the composite matrix is ​​washed and dried to obtain a pure composite, the prepared composite matrix is ​​characterized, and the structure and properties of the composite matrix are confirmed.

[0039] S2. Microencapsulation: The extract concentrate is encapsulated into a composite matrix by emulsification to form microcapsules, and the microcapsules are ensured to have good sphericity and uniform particle size;

[0040] The specific steps are as follows: phospholipids are selected as emulsifiers, the oil phase and the water phase are mixed in a ratio of 6:1, and a homogenizer is used for preliminary emulsification to form colostrum; the colostrum is processed by a high-pressure homogenizer to reduce the size of the droplets to form a more uniform emulsion, and glutaraldehyde is added to initiate cross-linking of the polymer in the composite matrix, thereby solidifying the droplets in the emulsion to form microcapsules; the microcapsules are separated by centrifugation and filtration, and the microcapsules are washed with ethanol to remove residual emulsifiers, unreacted polymers and impurities, and the washed microcapsules are vacuum dried to remove moisture to obtain dry microcapsules, and finally the prepared microcapsules are subjected to particle size analysis, morphological observation, drug loading and encapsulation efficiency determination to confirm the quality of the microcapsules.

[0041] The specific steps for extracting the concentrate are:

[0042] S201. Select fresh, pest-free pumpkin pedicles as raw materials, wash the pumpkin pedicles, remove the dirt and impurities on the surface, and chop the pumpkin pedicles;

[0043] S202. The pretreated pumpkin pedicles were mixed with an extraction solvent in a ratio of 1:10 by an ultrasonic extraction method, and extracted using an ultrasonic extractor. The temperature during the extraction process was set to 25-50 ° C, the time was 15-60min, and the power was 200-800W;

[0044] S203. The extract is concentrated under reduced pressure to remove the solvent to obtain a concentrate, and the temperature and pressure are controlled during the concentration process to avoid decomposition and loss of the active ingredient;

[0045] S204. The concentrated solution is purified to remove impurities, and finally the drug content and active ingredients of the extract are identified.

[0046] Specifically, in S203, use a vacuum distillation device to ensure that the inside of the equipment is clean, install the condenser and the collection bottle, adjust the power of the vacuum pump, and the vacuum degree is 100-200mbar. Turn on the heater to heat the extract to a temperature close to the boiling point of the solvent, but not exceeding the boiling point of the solvent to prevent the decomposition of the active ingredients. As the heat is applied, the solvent begins to evaporate, and the evaporated solvent is condensed through the condenser and then collected in the collection bottle. Continue to heat the extract until the solvent is completely evaporated, and check the collection bottle regularly to ensure that no solvent remains. When the solvent is completely evaporated, turn off the heater, wait for the equipment to cool to room temperature, then turn off the vacuum pump, and transfer the concentrate to a suitable container for filtration to remove residual solid matter.

[0047] Specifically, in S204, the concentrated solution is filtered using a microporous filter membrane to remove larger solid particles and impurities, the filtered concentrated solution is centrifuged to further remove tiny particles and impurities, activated carbon is added for adsorption to remove color and odor, and the concentrated solution is separated using an ultrafiltration membrane to remove impurities with smaller molecular weights. Liquid chromatography is used to separate and purify the effective ingredients, and the purified concentrated solution is dried to remove residual solvents and water.

[0048] S3. Condensation granulation: put the prepared microcapsules into a pill machine, use liquid nitrogen as a cooling medium to drop the microcapsules into the cooling medium, and quickly condense to form solid pills. Collect the condensed pills, dry them, remove the residual cooling medium, and obtain the final pumpkin pedicle pills.

[0049] The specific steps are as follows: preheat the dripper of the pill machine to reduce the adhesion of the microcapsules during the dripping process, and transport the prepared microcapsules to the hopper of the pill machine through a conveying device to ensure that the microcapsules are evenly distributed in the hopper to avoid clogging the dripper; pour liquid nitrogen into a low-temperature resistant container as a cooling medium, prepare liquid nitrogen, start the pill machine, drip the microcapsules into the liquid nitrogen through the dripper, control the distance between the dripper and the surface of the liquid nitrogen, and keep the distance at 3 cm to ensure that the microcapsules can be quickly condensed when dripped into the liquid nitrogen; after the microcapsules come into contact with the liquid nitrogen, they quickly lose heat, causing the internal matrix and shell materials to solidify quickly, and the microcapsules form a solid state in the liquid nitrogen while maintaining a spherical shape, and the cooling The condensed solid pellets float on the surface of liquid nitrogen. Use a funnel to collect the pellets from the liquid nitrogen and transfer the collected pellets to a dryer for vacuum drying to remove residual liquid nitrogen and moisture. Start drying at below 0°C and then gradually increase the temperature to no more than 40°C to avoid destroying the active ingredients of the drug. The drying time is 8-24 hours. During the drying process, the residual liquid nitrogen sublimates along with the moisture and is removed. Turn off the vacuum dryer and let the pellets cool naturally to room temperature in the dryer. Screen the dried pellets to remove unqualified particles and conduct quality inspections on the particle size, weight, drug content and drug release characteristics of the pellets.

[0050] Experimental Example 1

[0051] The drug yield is calculated based on the active ingredient content in the pumpkin pedicle raw material. The specific steps are as follows:

[0052] For the determination of the content of effective ingredients in the pumpkin stalk raw material, 100 g of pumpkin stalk raw material was taken, dried and analyzed by mass spectrometry, and the content of polysaccharide components in the pumpkin stalk raw material was found to be 1000 mg.

[0053] According to the preparation method of pumpkin stalk dropping pills of the present invention, the pumpkin stalk is mixed with an extraction solvent and subjected to ultrasonic extraction, the extract is concentrated under reduced pressure to obtain a concentrated solution, the concentrated solution is purified, and the purified extract is dried to obtain a dried extract.

[0054] For the determination of the content of the active ingredient in the Pumpkin Stem Drop Pills, 100 mg of the dry extract was taken and analyzed by mass spectrometry, which showed that the content of polysaccharide components in the Pumpkin Stem Drop Pills was 50 mg.

[0055] Calculate drug yield:

[0056] Drug yield = (the content of active ingredients in pumpkin pedicle pills / the content of active ingredients in pumpkin pedicle raw materials) * 100%

[0057] Drug yield = (50mg / 1000mg)*100% = 5%

[0058] The drug yield in the preparation process of pumpkin stalk pills is 5%, indicating that during the extraction process, 5% of the polysaccharide components are extracted from the pumpkin stalk raw material and successfully encapsulated in the pills.

[0059] Experimental Example 2

[0060] Liquid chromatography-mass spectrometry (LC-MS) was used to detect the active ingredients in pumpkin pedicle pills and analyze their purity and concentration.

[0061] Sample preparation: Take out 100 mg of sample from the prepared pumpkin pedicle dripping pills and grind it.

[0062] The ground samples were dried to remove residual solvent and water.

[0063] LC-MS analysis: The dried samples were analyzed using LC-MS.

[0064] The analysis conditions were set as follows: the mobile phase was 0.1% formic acid aqueous solution, the column temperature was 30° C., and the flow rate was 1 mL / min.

[0065] Result record: Collect the analysis results and obtain the peak area of ​​the polysaccharide component as 5000, the peak shape is sharp and symmetrical, and the purity is 95%. The concentration of the polysaccharide component is calculated to be 50 mg / mL.

[0066] Experimental Example 3

[0067] Experimental purpose: To evaluate the stability of pumpkin pedicle pills through accelerated testing and long-term sample observation.

[0068] Experimental materials: Pumpkin stem dripping pill samples

[0069] Analytical instrument: LC-MS technology

[0070] Experimental steps:

[0071] A certain amount of pumpkin stem dripping pills samples were taken and divided into two groups; one group of samples was placed in a constant temperature and humidity chamber with a set temperature of 40°C and a relative humidity of 75%; the other group of samples was stored at room temperature.

[0072] Each group of samples was analyzed by liquid chromatography-mass spectrometry on days 0, 10, 20, 30, 40 and 50 to detect the peak area, peak shape, purity and concentration of the active ingredients.

[0073] Long-term sample observation: Take a certain amount of pumpkin pedicle dripping pills and divide them into several groups; each group of samples is stored at room temperature for 1 month, 2 months, 3 months, 6 months, and 1 year. At the end of each storage period, the samples are analyzed by LC-MS to detect the peak area, peak shape, purity, and concentration of the active ingredients.

[0074] Result recording and analysis: Record each analysis result, including the peak area, peak shape, purity and concentration of the active ingredient. Analyze the stability of the sample under different storage conditions and determine the degradation of the active ingredient, as shown in the following table:

[0075]

[0076] Experimental results: The results of the accelerated test showed that the peak area, peak shape, purity and concentration of the active ingredient in the Pumpkin Stem Pills decreased under high temperature and high humidity conditions; the results of long-term sample observations showed that the peak area, peak shape, purity and concentration of the active ingredient in the Pumpkin Stem Pills remained relatively stable when stored at room temperature.

[0077] In summary, the present invention adopts a method combining microwave-assisted extraction and carbon dioxide supercritical fluid extraction to improve the extraction efficiency and activity of the effective ingredients in pumpkin pedicles. A novel biodegradable polymer and a natural polymer material are used to prepare the drop pill matrix, which improves the sustained release performance and stability of the drop pills. The extract concentrate is encapsulated in the composite matrix by microencapsulation technology to form microcapsules, and then the drop pills are prepared by the dripping method, which improves the stability and release characteristics of the drug.

[0078] Parts not involved in the present invention are the same as the prior art or can be implemented by the prior art. Although the embodiments of the present invention have been shown and described, it is understood by those skilled in the art that various changes, modifications, substitutions and variations can be made to these embodiments without departing from the principles and spirit of the present invention, and the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A method for preparing pumpkin pedicle dripping pills, characterized in that: The following steps are involved: S1. Preparation of composite matrix: polylactic acid-co-glycolic acid PLGA and chitosan are mixed in a certain proportion, and compounded by chemical method to prepare a matrix of drop pills; S2. Microencapsulation: The extract concentrate is encapsulated into a composite matrix by emulsification to form microcapsules, and the microcapsules are ensured to have good sphericity and uniform particle size; S3. Condensation granulation: put the prepared microcapsules into a pill machine, use liquid nitrogen as a cooling medium to drop the microcapsules into the cooling medium, and quickly condense to form solid pills. Collect the condensed pills, dry them, remove the residual cooling medium, and obtain the final pumpkin pedicle pills.

2. The method for preparing pumpkin pedicle dripping pills according to claim 1, characterized in that: In step S1, the specific steps are: Weigh PLGA and chitosan in a ratio of 90:10-70:30, pre-dry the PLGA particles at room temperature to remove moisture to ensure that it dissolves with the chitosan during the mixing process, add the chitosan to a 1-2% acetic acid solution, heat and stir until the chitosan is completely dissolved; Carboxyl groups with reactive groups were introduced into chitosan molecules, and PLGA introduced amine groups through chemical reactions to promote the binding with chitosan; The pre-dried PLGA particles were added to the dissolved chitosan solution and the mixture was stirred at room temperature using a magnetic stirrer to ensure that the PLGA and chitosan were evenly distributed for 1-2 h; After compounding by chemical methods, the prepared composite matrix is ​​characterized to confirm the structure and properties of the composite matrix.

3. A method for preparing pumpkin stem dripping pills according to claim 1 or 2, characterized in that: The specific steps of compounding PLGA and chitosan by chemical method are as follows: The functionalized PLGA and chitosan are mixed together, and in the presence of carbodiimide, the carboxyl groups on the PLGA react with the amine groups on the chitosan to form amide bonds, the pH value is maintained at 4.5-6.5, the reaction temperature is 30°C-60°C, the reaction time is 40-90 minutes, and dimethylformamide is used to dissolve the PLGA and chitosan without interfering with the amidation reaction. After the reaction is completed, unreacted raw materials and by-products are removed by dialysis and centrifugation, and the composite matrix is ​​washed and dried to obtain a pure composite.

4. The method for preparing pumpkin stem dripping pills according to claim 1, characterized in that: In step S2, the specific steps of preparing microcapsules using emulsification technology are: Using phospholipids as emulsifiers, the oil phase and the water phase are mixed in a ratio of 6:1, and a homogenizer is used for preliminary emulsification to form colostrum; the colostrum is processed by a high-pressure homogenizer to reduce the size of the droplets to form a more uniform emulsion, and glutaraldehyde is added to initiate cross-linking of the polymer in the composite matrix, thereby solidifying the droplets in the emulsion to form microcapsules; the microcapsules are separated by centrifugation and filtration, and the microcapsules are washed with ethanol to remove residual emulsifiers, unreacted polymers and impurities. The washed microcapsules are vacuum dried to remove moisture to obtain dry microcapsules, and finally the prepared microcapsules are subjected to particle size analysis, morphological observation, drug loading and encapsulation efficiency determination to confirm the quality of the microcapsules.

5. The method for preparing pumpkin stem dripping pills according to claim 1, characterized in that: In S3, the specific steps of condensation granulation are: Preheat the dripping head of the pill machine to reduce the adhesion of microcapsules during the dripping process, and transport the prepared microcapsules to the hopper of the pill machine through the conveying device to ensure that the microcapsules are evenly distributed in the hopper to avoid clogging the dripping head; pour liquid nitrogen into a low-temperature resistant container as a cooling medium, prepare liquid nitrogen, start the pill machine, and drip the microcapsules into the liquid nitrogen through the dripping head. Control the distance between the dripping head and the surface of the liquid nitrogen, and keep the distance at 3 cm to ensure that the microcapsules can be quickly condensed when dripped into the liquid nitrogen; after the microcapsules come into contact with the liquid nitrogen, they quickly lose heat, causing the internal matrix and shell materials to solidify quickly, and the microcapsules form a solid state in the liquid nitrogen while maintaining a spherical shape. After condensation Solid pellets float on the surface of liquid nitrogen. Use a funnel to collect the pellets from the liquid nitrogen and transfer the collected pellets to a dryer for vacuum drying to remove residual liquid nitrogen and moisture. Start drying at below 0°C and then gradually increase the temperature to no more than 40°C to avoid destroying the active ingredients of the drug. The drying time is 8-24 hours. During the drying process, the residual liquid nitrogen sublimates along with the moisture and is removed. Turn off the vacuum dryer and let the pellets cool naturally to room temperature in the dryer. Screen the dried pellets to remove unqualified particles and perform quality inspections on the particle size, weight, drug content and drug release characteristics of the pellets.

6. The method for preparing pumpkin stem dripping pills according to claim 1, characterized in that: In step S2, the specific steps for extracting the concentrated solution are: S201. Select fresh, pest-free pumpkin pedicles as raw materials, wash the pumpkin pedicles, remove the dirt and impurities on the surface, and chop the pumpkin pedicles; S202. The pretreated pumpkin pedicles were mixed with an extraction solvent in a ratio of 1:10 by an ultrasonic extraction method, and extracted using an ultrasonic extractor. The temperature during the extraction process was set to 25-50 ° C, the time was 15-60min, and the power was 200-800W; S203. The extract is concentrated under reduced pressure to remove the solvent to obtain a concentrate, and the temperature and pressure are controlled during the concentration process to avoid decomposition and loss of the active ingredient; S204. The concentrated solution is purified to remove impurities, and finally the drug content and active ingredients of the extract are identified.